Publication:


abstract

OBJECTIVE:

To investigate the indications of amniocentesis for the detection of chromosomal abnormalities among a sample of patients in Southeast Turkey.

MATERIAL and METHODS:

Between 2004 and 2007, 1,068 second-trimester amniocentesis tests were performed in the Medical Biology and Genetics Department Laboratory at Dicle University. Amniotic fluids were cultured by using long-term tissue culture for prenatal diagnosis with cytogenetic analysis. The clinical and cytogenetic findings on 1,068 second-trimester amniocenteses were analyzed. The indications, the proportions of karyotypes according to indications and complications were summarized.

RESULTS:

Among the 1,068 amniocentesis cases, the maternal age between 35 and 39 years was the most common age group (34.5%). Of the clinical indications abnormal maternal serum screening results were the most common indication for amniocentesis (37.6%). Of 52 cases (4.9%) with detected chromosomal aberrations, 39 were numeric (27 trisomies, 10 sex chromosome aberrations and two triploidies) and 13 were structural (2 reciprocal translocations, 2 Robertsonian translocations and 6 inversions). The highest detection rate of chromosome aberrations was in cases undergoing amniocentesis for abnormal maternal serum screening combined with abnormal ultrasound (US) findings (8.0%).

CONCLUSION:

This study suggests that complementary measures, such as routine antenatal US and maternal serum screening, should be added to increase the efficiency of genetic amniocentesis. Therefore, the study could be used for the establishment of a database for genetic counseling.

Related Articles
Clinical and cytogenetic findings on 31,615 mid-trimester amniocenteses.
Korean J Lab Med. 2008
Clinical and cytogenetic findings on 31,615 mid-trimester amniocenteses.
Han SH, An JW, Jeong GY, Yoon HR, Lee A, Yang YH, Lee KP, Lee KR. Korean J Lab Med. 2008 Oct; 28(5):378-85.
Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk: result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population.
Acta Obstet Gynecol Scand. 1999
Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk: result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population.
Chao AS, Chung CL, Wu CD, Chang SD, Cheng PJ, Lin YT, Soong YK. Acta Obstet Gynecol Scand. 1999 May; 78(5):393-7.
Prenatal cytogenetic diagnosis in amniocentesis.
J Formos Med Assoc. 1992
Prenatal cytogenetic diagnosis in amniocentesis.
Hsieh FJ, Ko TM, Tseng LH, Chang LS, Pan MF, Chuang SM, Lee TY, Chen HY. J Formos Med Assoc. 1992 Mar; 91(3):276-82.
Review Prospective evaluation of prenatal maternal serum screening for trisomy 18.
Am J Obstet Gynecol. 1998
Review Prospective evaluation of prenatal maternal serum screening for trisomy 18.
Yankowitz J, Fulton A, Williamson R, Grant SS, Budelier WT. Am J Obstet Gynecol. 1998 Mar; 178(3):446-50.
Review Obstetrical complications associated with abnormal maternal serum markers analytes.
J Obstet Gynaecol Can. 2008
Review Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A, Wilson RD, Audibert F, Allen VM, Blight C, Brock JA, Désilets VA, Johnson JA, Langlois S, Summers A, et al. J Obstet Gynaecol Can. 2008 Oct; 30(10):918-49.